Oragenics Stock Technical Analysis
| OGEN Stock | USD 0.86 0.00 0.000001% |
As of the 26th of January, Oragenics holds the Risk Adjusted Performance of (0.10), variance of 15.46, and Coefficient Of Variation of (650.66). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oragenics, as well as the relationship between them.
Oragenics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oragenics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OragenicsOragenics | Build AI portfolio with Oragenics Stock |
Oragenics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 2.0 | Hold | 1 | Odds |
Most Oragenics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Oragenics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Oragenics, talking to its executives and customers, or listening to Oragenics conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oragenics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oragenics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oragenics.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Oragenics on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Oragenics or generate 0.0% return on investment in Oragenics over 90 days. Oragenics is related to or competes with AIM ImmunoTech, Kala Pharmaceuticals, Ensysce Biosciences, Soligenix, Can Fite, Xenetic Biosciences, and CNS Pharmaceuticals. Oragenics, Inc. develops antibiotics for infectious diseases in the United States More
Oragenics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oragenics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oragenics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 19.9 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 4.55 |
Oragenics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oragenics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oragenics' standard deviation. In reality, there are many statistical measures that can use Oragenics historical prices to predict the future Oragenics' volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.64) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oragenics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oragenics January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 2.98 | |||
| Coefficient Of Variation | (650.66) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.46 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 19.9 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 4.55 | |||
| Skewness | 0.1172 | |||
| Kurtosis | 0.6697 |
Oragenics Backtested Returns
Oragenics maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15 % return per unit of risk over the last 3 months. Oragenics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oragenics' Risk Adjusted Performance of (0.10), variance of 15.46, and Coefficient Of Variation of (650.66) to confirm the risk estimate we provide. The company holds a Beta of 0.96, which implies possible diversification benefits within a given portfolio. Oragenics returns are very sensitive to returns on the market. As the market goes up or down, Oragenics is expected to follow. At this point, Oragenics has a negative expected return of -0.6%. Please make sure to check Oragenics' jensen alpha, as well as the relationship between the skewness and day typical price , to decide if Oragenics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.62 |
Very good reverse predictability
Oragenics has very good reverse predictability. Overlapping area represents the amount of predictability between Oragenics time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oragenics price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Oragenics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Oragenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Oragenics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oragenics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Oragenics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oragenics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oragenics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oragenics price pattern first instead of the macroeconomic environment surrounding Oragenics. By analyzing Oragenics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oragenics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oragenics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 6.66E-4 | 3.66E-4 | Price To Sales Ratio | 1.6K | 2.9K |
Oragenics January 26, 2026 Technical Indicators
Most technical analysis of Oragenics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oragenics from various momentum indicators to cycle indicators. When you analyze Oragenics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 2.98 | |||
| Coefficient Of Variation | (650.66) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.46 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 19.9 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 4.55 | |||
| Skewness | 0.1172 | |||
| Kurtosis | 0.6697 |
Oragenics January 26, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Oragenics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.11 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.85 | ||
| Day Typical Price | 0.85 | ||
| Price Action Indicator | 0.01 | ||
| Market Facilitation Index | 0.10 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.